JPMorgan Europe Research Enhanced Index Equity Active (LON:JRED)
London · Delayed Price · Currency is GBP · Price in EUR 44.88
+0.10 (0.22%)
At close: Oct 24, 2025
0.22% (1Y)
| Assets | 102.76M |
| Expense Ratio | 0.25% |
| PE Ratio | 16.13 |
| Dividend (ttm) | 0.89 |
| Dividend Yield | 2.28% |
| Ex-Dividend Date | Oct 9, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | 32.14% |
| 1-Year Return | +12.31% |
| Volume | 12 |
| Open | 44.69 |
| Previous Close | 44.79 |
| Day's Range | 44.69 - 44.88 |
| 52-Week Low | 36.41 |
| 52-Week High | 44.88 |
| Beta | n/a |
| Holdings | 148 |
| Inception Date | Sep 15, 2021 |
About JRED
JRDE.L was created on 2021-09-15 by JPMorgan. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 117.08m in AUM and 143 holdings. The Sub-Fund aims to achieve a long-term return in excess of MSCI Europe Index (Total Return Net) (the Benchmark) by actively investing primarily in a portfolio of European companies.
Asset Class Equity
Category Total Market
Stock Exchange London Stock Exchange
Ticker Symbol JRED
Provider JPMorgan
Performance
JRED had a total return of 12.31% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.33%.
Top 10 Holdings
22.79% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 3.60% |
| Siemens Aktiengesellschaft | SIE | 2.42% |
| Shell plc | SHEL | 2.41% |
| AstraZeneca PLC | AZN | 2.39% |
| Nestlé S.A. | NESN | 2.28% |
| Allianz SE | ALV | 2.03% |
| SAP SE | SAP | 1.95% |
| Schneider Electric S.E. | SU | 1.92% |
| HSBC Holdings plc | HSBA | 1.90% |
| Novartis AG | NOVN | 1.89% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Oct 9, 2025 | £0.10607 | Nov 7, 2025 |
| Jul 10, 2025 | £0.4642 | Aug 7, 2025 |
| Apr 10, 2025 | £0.21622 | May 7, 2025 |
| Jan 16, 2025 | £0.09365 | Feb 7, 2025 |
| Oct 10, 2024 | £0.15758 | Nov 7, 2024 |
| Jul 11, 2024 | £0.47031 | Aug 7, 2024 |